Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 2009, 59 (4): 225-249. 10.3322/caac.20006.
Article
PubMed
Google Scholar
Bolufer P, Molina R, Ruiz A, Hernandez M, Vazquez C, Lluch A: Estradiol receptors in combination with neu or myc oncogene amplifications might define new subtypes of breast cancer. Clin Chim Acta. 1994, 229 (1-2): 107-122. 10.1016/0009-8981(94)90233-X.
Article
CAS
PubMed
Google Scholar
La Vecchia C, Franceschi S, Lucchini F, Levi F: International Variations and Trends in the Incidence of Breast Cancer in Older Women. Cancer Control. 1994, 1 (4): 327-333.
PubMed
Google Scholar
Marugame T, Katanoda K: International comparisons of cumulative risk of breast and prostate cancer, from cancer incidence in five continents Vol. VIII. Jpn J Clin Oncol. 2006, 36 (6): 399-400. 10.1093/jjco/hyl049.
Article
PubMed
Google Scholar
Rosen M, Lundin A, Nystrom L, Rutqvist LE, Stenbeck M, Talback M: [Incidence and mortality of breast cancer during a 25-year period. International and regional comparisons]. Lakartidningen. 2000, 97 (4): 294-299.
CAS
PubMed
Google Scholar
Morabia A, Costanza MC: Reproductive factors and incidence of breast cancer: an international ecological study. Soz Praventivmed. 2000, 45 (6): 247-257. 10.1007/BF01591687.
Article
CAS
PubMed
Google Scholar
Boyd ZS, Wu QJ, O'Brien C, Spoerke J, Savage H, Fielder PJ, Amler L, Yan Y, Lackner MR: Proteomic analysis of breast cancer molecular subtypes and biomarkers of response to targeted kinase inhibitors using reverse-phase protein microarrays. Mol Cancer Ther. 2008, 7 (12): 3695-3706. 10.1158/1535-7163.MCT-08-0810.
Article
CAS
PubMed
Google Scholar
Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, et al: Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006, 295 (21): 2492-2502. 10.1001/jama.295.21.2492.
Article
CAS
PubMed
Google Scholar
Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO: Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res. 2008, 14 (5): 1368-1376. 10.1158/1078-0432.CCR-07-1658.
Article
CAS
PubMed
Google Scholar
Onitilo AA, Engel JM, Greenlee RT, Mukesh BN: Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res. 2009, 7 (1-2): 4-13. 10.3121/cmr.2009.825.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sims AH, Howell A, Howell SJ, Clarke RB: Origins of breast cancer subtypes and therapeutic implications. Nat Clin Pract Oncol. 2007, 4 (9): 516-525. 10.1038/ncponc0908.
Article
CAS
PubMed
Google Scholar
Sorlie T: Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer. 2004, 40 (18): 2667-2675. 10.1016/j.ejca.2004.08.021.
Article
CAS
PubMed
Google Scholar
Couris CM, Polazzi S, Olive F, Remontet L, Bossard N, Gomez F, Schott AM, Mitton N, Colonna M, Trombert B: Breast cancer incidence using administrative data: correction with sensitivity and specificity. J Clin Epidemiol. 2009, 62 (6): 660-666. 10.1016/j.jclinepi.2008.07.013.
Article
PubMed
Google Scholar
Deapen D, Liu L, Perkins C, Bernstein L, Ross RK: Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer. 2002, 99 (5): 747-750. 10.1002/ijc.10415.
Article
CAS
PubMed
Google Scholar
Lee SY, Jeong SH, Kim YN, Kim J, Kang DR, Kim HC, Nam CM: Cost-effective mammography screening in Korea: high incidence of breast cancer in young women. Cancer Sci. 2009, 100 (6): 1105-1111. 10.1111/j.1349-7006.2009.01147.x.
Article
CAS
PubMed
Google Scholar
Lin CH, Liau JY, Lu YS, Huang CS, Lee WC, Kuo KT, Shen YC, Kuo SH, Lan C, Liu JM, et al: Molecular subtypes of breast cancer emerging in young women in Taiwan: evidence for more than just westernization as a reason for the disease in Asia. Cancer Epidemiol Biomarkers Prev. 2009, 18 (6): 1807-1814. 10.1158/1055-9965.EPI-09-0096.
Article
CAS
PubMed
Google Scholar
Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE: Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat. 2008, 110 (1): 183-188. 10.1007/s10549-007-9694-5.
Article
CAS
PubMed
Google Scholar
Ihemelandu CU, Leffall LD, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA: Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival. J Surg Res. 2007, 143 (1): 109-118. 10.1016/j.jss.2007.03.085.
Article
CAS
PubMed
Google Scholar
Nichols HB, Trentham-Dietz A, Love RR, Hampton JM, Hoang Anh PT, Allred DC, Mohsin SK, Newcomb PA: Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women. Cancer Epidemiol Biomarkers Prev. 2005, 14 (1): 41-47.
CAS
PubMed
Google Scholar
Akiyama F, Iwase H: Triple negative breast cancer: clinicopathological characteristics and treatment strategies. Breast Cancer. 2009, 16 (4): 252-3. 10.1007/s12282-009-0140-x.
Article
PubMed
Google Scholar
Alli E, Sharma VB, Sunderesakumar P, Ford JM: Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase. Cancer Res. 2009, 69 (8): 3589-3596. 10.1158/0008-5472.CAN-08-4016.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bouchalova K, Cizkova M, Cwiertka K, Trojanec R, Hajduch M: Triple negative breast cancer--current status and prospective targeted treatment based on HER1 (EGFR), TOP2A and C-MYC gene assessment. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009, 153 (1): 13-17.
Article
CAS
PubMed
Google Scholar
Carey LA, Dees EC, Sawyer L, Gatti L, Moore DT, Collichio F, Ollila DW, Sartor CI, Graham ML, Perou CM: The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes. Clin Cancer Res. 2007, 13 (8): 2329-2334. 10.1158/1078-0432.CCR-06-1109.
Article
CAS
PubMed
Google Scholar
Gajalakshmi P, Natarajan TG, Selvi Rani D, Thangaraj K: A novel BRCA1 mutation in an Indian family with hereditary breast/ovarian cancer. Breast Cancer Res Treat. 2007, 101 (1): 3-6. 10.1007/s10549-006-9267-z.
Article
CAS
PubMed
Google Scholar
Ghumare SS, Cunningham JE: Breast cancer trends in Indian residents and emigrants portend an emerging epidemic for India. Asian Pac J Cancer Prev. 2007, 8 (4): 507-512.
PubMed
Google Scholar
Goggins WB, Wong G: Cancer among Asian Indians/Pakistanis living in the United States: low incidence and generally above average survival. Cancer Causes Control. 2009, 20 (5): 635-643. 10.1007/s10552-008-9275-x.
Article
PubMed
Google Scholar
Hebert JR, Ghumare SS, Gupta PC: Stage at diagnosis and relative differences in breast and prostate cancer incidence in India: comparison with the United States. Asian Pac J Cancer Prev. 2006, 7 (4): 547-555.
PubMed
Google Scholar
Jack RH, Davies EA, Moller H: Breast cancer incidence, stage, treatment and survival in ethnic groups in South East England. Br J Cancer. 2009, 100 (3): 545-550. 10.1038/sj.bjc.6604852.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kamath SK, Murillo G, Chatterton RT, Hussain EA, Amin D, Mortillaro E, Peterson CT, Alekel DL: Breast cancer risk factors in two distinct ethnic groups: Indian and Pakistani vs. American premenopausal women. Nutr Cancer. 1999, 35 (1): 16-26. 10.1207/S1532791416-26.
Article
CAS
PubMed
Google Scholar
Murthy NS, Agarwal UK, Chaudhry K, Saxena S: A study on time trends in incidence of breast cancer - Indian scenario. Eur J Cancer Care (Engl). 2007, 16 (2): 185-186. 10.1111/j.1365-2354.2006.00761.x.
Article
CAS
Google Scholar
Raju GC, Naraynsingh V: Breast cancer in West Indian women in Trinidad. Trop Geogr Med. 1989, 41 (3): 257-260.
CAS
PubMed
Google Scholar
Rao R, Kuerer H, Cristofanilli M, Brigilio K, Shukla S, Rao M, Krishnamurthy S: Breast cancer in the asian Indian population of the United States: a call for screening and education. Breast J. 2008, 14 (4): 402-403. 10.1111/j.1524-4741.2008.00613.x.
Article
PubMed
Google Scholar
Rastogi T, Devesa S, Mangtani P, Mathew A, Cooper N, Kao R, Sinha R: Cancer incidence rates among South Asians in four geographic regions: India, Singapore, UK and US. Int J Epidemiol. 2008, 37 (1): 147-160. 10.1093/ije/dym219.
Article
PubMed
Google Scholar
Dey S, Boffetta P, Mathews A, Brennan P, Soliman A, Mathew A: Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India. Int J Cancer. 2009, 125 (7): 1663-70. 10.1002/ijc.24460.
Article
CAS
PubMed
Google Scholar
Kumar VL, Srivastava A, Singhal R, Kumar V: Immunoreactive estrogen receptor in breast tumor and adjacent tissue: association with clinicopathological characteristics in Indian population. J Surg Oncol. 2005, 89 (4): 251-255. 10.1002/jso.20211.
Article
CAS
PubMed
Google Scholar
Navani S, Bhaduri AS: High incidence of oestrogen receptor negative progesterone receptor positive phenotype in Indian breast cancer: fact or fiction?. Indian J Pathol Microbiol. 2005, 48 (2): 199-201.
PubMed
Google Scholar
Seshadri R, Shah PN: Steroid receptors in breast cancer in Indian women. Anticancer Res. 1984, 4 (6): 403-407.
CAS
PubMed
Google Scholar
Shet T, Agrawal A, Nadkarni M, Palkar M, Havaldar R, Parmar V, Badwe R, Chinoy RF: Hormone receptors over the last 8 years in a cancer referral center in India: what was and what is?. Indian J Pathol Microbiol. 2009, 52 (2): 171-174. 10.4103/0377-4929.48909.
Article
PubMed
Google Scholar
Wu TY, West B, Chen YW, Hergert C: Health beliefs and practices related to breast cancer screening in Filipino, Chinese and Asian-Indian women. Cancer Detect Prev. 2006, 30 (1): 58-66. 10.1016/j.cdp.2005.06.013.
Article
PubMed
Google Scholar
Blesch KS, Davis F, Kamath SK: A comparison of breast and colon cancer incidence rates among native Asian Indians, US immigrant Asian Indians, and whites. J Am Diet Assoc. 1999, 99 (10): 1275-1277. 10.1016/S0002-8223(99)00313-2.
Article
CAS
PubMed
Google Scholar
Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, Bhatnagar A, Chintamani C, Sharma PC, Saxena S: Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detect Prev. 2009, 32 (5-6): 386-394. 10.1016/j.canep.2009.04.012.
Article
CAS
PubMed
Google Scholar
Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V: Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007, 109 (9): 1721-1728. 10.1002/cncr.22618.
Article
PubMed
Google Scholar
Bertolo C, Guerrero D, Vicente F, Cordoba A, Esteller M, Ropero S, Guillen-Grima F, Martinez-Penuela JM, Lera JM: Differences and molecular immunohistochemical parameters in the subtypes of infiltrating ductal breast cancer. Am J Clin Pathol. 2008, 130 (3): 414-424. 10.1309/J3QV9763DYPV338D.
Article
CAS
PubMed
Google Scholar
Del Casar JM, Martin A, Garcia C, Corte MD, Alvarez A, Junquera S, Gonzalez LO, Bongera M, Garcia-Muniz JL, Allende MT, et al: Characterization of breast cancer subtypes by quantitative assessment of biological parameters: relationship with clinicopathological characteristics, biological features and prognosis. Eur J Obstet Gynecol Reprod Biol. 2008, 141 (2): 147-152. 10.1016/j.ejogrb.2008.07.021.
Article
CAS
PubMed
Google Scholar
Desmedt C, Haibe-Kains B, Wirapati P, Buyse M, Larsimont D, Bontempi G, Delorenzi M, Piccart M, Sotiriou C: Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clin Cancer Res. 2008, 14 (16): 5158-5165. 10.1158/1078-0432.CCR-07-4756.
Article
CAS
PubMed
Google Scholar
Hannemann J, Kristel P, van Tinteren H, Bontenbal M, van Hoesel QG, Smit WM, Nooij MA, Voest EE, Wall van der E, Hupperets P, et al: Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy. Br J Cancer. 2006, 95 (10): 1334-1341. 10.1038/sj.bjc.6603449.
Article
CAS
PubMed
PubMed Central
Google Scholar
Harris LN, Broadwater G, Lin NU, Miron A, Schnitt SJ, Cowan D, Lara J, Bleiweiss I, Berry D, Ellis M, et al: Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342. Breast Cancer Res. 2006, 8 (6): R66-10.1186/bcr1622.
Article
PubMed
PubMed Central
Google Scholar
Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J, Lindahl T, Pawitan Y, Hall P, Nordgren H, et al: Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res. 2006, 66 (21): 10292-10301. 10.1158/0008-5472.CAN-05-4414.
Article
CAS
PubMed
Google Scholar
Rosenberg LU, Magnusson C, Lindstrom E, Wedren S, Hall P, Dickman PW: Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study. Breast Cancer Res. 2006, 8 (1): R11-10.1186/bcr1378.
Article
PubMed
PubMed Central
Google Scholar
Ben Hamida A, Labidi IS, Mrad K, Charafe-Jauffret E, Ben Arab S, Esterni B, Xerri L, Viens P, Bertucci F, Birnbaum D, et al: Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin. BMC Cancer. 2008, 8: 28-10.1186/1471-2407-8-28.
Article
PubMed
PubMed Central
Google Scholar
Bertucci F, Finetti P, Rougemont J, Charafe-Jauffret E, Cervera N, Tarpin C, Nguyen C, Xerri L, Houlgatte R, Jacquemier J, et al: Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. Cancer Res. 2005, 65 (6): 2170-2178. 10.1158/0008-5472.CAN-04-4115.
Article
CAS
PubMed
Google Scholar
Van Laere SJ, Eynden Van den GG, Auwera Van der I, Vandenberghe M, van Dam P, Van Marck EA, van Golen KL, Vermeulen PB, Dirix LY: Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling. Breast Cancer Res Treat. 2006, 95 (3): 243-255. 10.1007/s10549-005-9015-9.
Article
PubMed
Google Scholar
Chan SW, LaVigne KA, Port ER, Fey JV, Brogi E, Borgen PI, Cody HS: Does the benefit of sentinel node frozen section vary between patients with invasive duct, invasive lobular, and favorable histologic subtypes of breast cancer?. Ann Surg. 2008, 247 (1): 143-149. 10.1097/SLA.0b013e3181581f41.
Article
PubMed
Google Scholar
Wong SL, Chao C, Edwards MJ, Carlson DJ, Laidley A, Noyes RD, McGlothin T, Ley PB, Tuttle T, Schadt M, et al: Frequency of sentinel lymph node metastases in patients with favorable breast cancer histologic subtypes. Am J Surg. 2002, 184 (6): 492-498. 10.1016/S0002-9610(02)01057-7.
Article
PubMed
Google Scholar
Dinshaw KA, Sarin R, Budrukkar AN, Shrivastava SK, Deshpande DD, Chinoy RF, Badwe R, Hawaldar R: Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial Hospital. J Surg Oncol. 2006, 94 (2): 105-113. 10.1002/jso.20497.
Article
PubMed
Google Scholar
Vyas JJ, Desai PB, Sampat MB, Shinde SR, Rao DN, Sarkar S, Badwe R, Tiwari J, Koppikar A: Observations on Indian node-negative breast cancer patients: a multivariate analysis. J Surg Oncol. 1989, 42 (4): 256-263. 10.1002/jso.2930420411.
Article
CAS
PubMed
Google Scholar
Pestonjamasp PH, Mittra I: Analysis of BRCA1 involvement in breast cancer in Indian women. J Biosci. 2000, 25 (1): 19-23. 10.1007/BF02985177.
Article
CAS
PubMed
Google Scholar
Saxena S, Chakraborty A, Kaushal M, Kotwal S, Bhatanager D, Mohil RS, Chintamani C, Aggarwal AK, Sharma VK, Sharma PC, et al: Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. BMC Med Genet. 2006, 7: 75-10.1186/1471-2350-7-75.
Article
PubMed
PubMed Central
Google Scholar
Saxena S, Szabo CI, Chopin S, Barjhoux L, Sinilnikova O, Lenoir G, Goldgar DE, Bhatanager D: BRCA1 and BRCA2 in Indian breast cancer patients. Hum Mutat. 2002, 20 (6): 473-474. 10.1002/humu.9082.
Article
PubMed
Google Scholar
Keam B, Im SA, Kim HJ, Oh DY, Kim JH, Lee SH, Chie EK, Han W, Kim DW, Moon WK, et al: Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer. BMC Cancer. 2007, 7: 203-10.1186/1471-2407-7-203.
Article
PubMed
PubMed Central
Google Scholar
Comments
View archived comments (1)